NLRP3 and Alzheimer disease: Notably, the upregulation of NLRP3 inflammasome-produced IL-1β in AD patients' brains (Kálmán et al., 1997; Benzing et al., 1999; Griffin et al., 2000) can lead to cognitive dysfunction.